Document is current
Any future updates will be listed below
-
Authors
Laws, Alison
Leonard, Saskia
Vincuilla, Julie
Parker, Tonia
Kantor, Olga
Mittendorf, Elizabeth A.
Weiss, Anna
King, Tari A.
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 19 November 2024
First Online: 4 December 2024
Disclosures
: EAM reports compensated service on scientific advisory boards for AstraZeneca, BioNTech, Merck, and Moderna; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speakers honoraria and travel support from Merck Sharp and Dohme; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. EAM also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. TAK reports speaker honoraria for Exact Sciences and compensated service on the FES Steering Committee, GE Healthcare, and compensated service as faculty for PrecisCa cancer information service. The remaining authors declare no conflicts of interest.
